The audience can see the famous scientist's life unfold in Palaver Tree Theater's production of "The Half-Life of Marie Curie ...
Forbes contributors publish independent expert analyses and insights. GrrlScientist writes about evolution, ecology, behavior and health. This voice experience is generated by AI. Learn more. This ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Find out what’s new to watch this week on streaming services such as Netflix, Disney+, Apple TV, Prime Video, Paramount+, BritBox, Crave, CBC Gem and digital. One new movie made the top five and last ...
The Musée Curie, nestled in the historic heart of Paris near the Panthéon, offers a compelling journey through the ...
International healthcare investment group OrbiMed has raised around $4.3 billion in committed financing for distribution across three new private funds that will be used to support life sciences ...
Netherlands-based investment group Gilde Healthcare has finally closed its new Venture & Growth VI fund with committed funding of €740 million, well ahead of its original target of €600 million. The ...
ANOTHER ONE: Taylor LaJoie has left the White House, where he most recently served in the legislative affairs office, to join Alpine Group as a vice president. LaJoie has been serving as a special ...
Synthetic biology is the design and construction of new biological parts, devices, and systems, and the re-design of existing, natural biological systems for useful purposes. Although synthetic gene ...
Hosted on MSN
1.2 billion-year-old water discovered deep underground in a mine, can we take a sip of it?
Scientists have found groundwater dating back 1.2 billion years in the Moab Khotsong gold and uranium mine, located in South Africa’s Witwatersrand Basin. The find, buried 3 kilometers beneath the ...
Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson and Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results